Fiziksel Aktivite ve Vücut Kitle İndeksi ile Menopozal Semptomların İlişkisi: Kesitsel Çalışma
Year 2020,
Volume: 17 Issue: 1, 269 - 274, 31.03.2020
Vehbi Yavuz Tokgöz
,
Şebnem Alanya Tosun
Abstract
Amaç: Çalışmamızın amacı menopozal dönemdeki kadınların yaşadıkları menopozal semptomların sosyodemografik durumları, fiziksel aktivite durumu ve vücut kitle indeksleri ile ilişkisini değerlendirmektir.
Gereç ve Yöntemler: Kesitsel tipte yapılan bu araştırmanın verileri Ocak-Haziran 2017 tarihleri arasında Giresun Üniversitesi Tıp Fakültesi Kadın Hastalıkları ve Doğum Polikliniği’ne başvuran perimenopozal ve menopozal dönemde olan kadınlardan elde edilmiştir. Çalışma dışlanma kriterleri sonrası toplamda 105 kadının verileri incelenerek yapılmıştır. Veriler araştırmacılar tarafından hazırlanan bilgi formu ve menopozal semptomların şiddetini ölçmek için menopoz ilişkili skala kullanılarak toplanmıştır.
Bulgular: Menopozal dönemdeki kadınların ortalama yaşları 51.3±9.3 yıl ve ortalama vücut kitle indeks değerleri 29.5±6.0 kg/m2 olarak bulunmuştur. Menopoz ilişkili semptom skorları(somatik skor, psikolojik skor, ürogenital skor ve toplam skor) sosyodemografik parametreler arasında değerlendirildiğinde; eğitim seviyesinin artışı ile ürogenital skor hariç diğer skorlarda belirgin azalma tespit edilmiştir(p<0.05). Düzenli egzersiz yapanlarda ise yalnızca somatik skorlarda anlamlı azalma saptanmıştır(p=0.04). Vücut kitle indeksi değerlerinin artışının ise genel olarak menopozal semptomlarda belirgin artış ile birlikte olduğu belirlenmiştir(p<0.05).
Sonuç: Düzenli egzersiz yapanlarda ve düşük vücut kitle indeksi değerine sahip olan menopozal kadınlarda özellikle somatik semptomlar ve psikolojik semptomlar daha az görülmektedir. Bazı kadınlar çeşitli sebeplerle hormon tedavilerini tercih etmemektedirler. Çalışmamızda bu gibi durumlarda etkin bir egzersiz programının, kilo azaltıcı yaklaşımların özellikle vazomotor semptomların daha az hissedilmesinde etkili olabileceği bulunmuştur.
References
- 1.Mishra G, Kuh D. Perceived change in quality of life during the menopause. Soc Sci Med 2006; 62:93-102.
2.Dennerstein L, Smith AM, Morse C. Psychological well-being, mid-life and the menopause. Maturitas 1994; 20:1-11.
3.Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999; 353:571-580.
4.North American Menopause S. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004; 11:11-33.
5.Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005; 118 Suppl 12B:14-24.
6.de Villiers TJ, Gass ML, Haines CJ, Hall JE, Lobo RA, Pierroz DD, et al. Global consensus statement on menopausal hormone therapy. Climacteric 2013; 16:203-204.
7.Morelli V, Naquin C. Alternative therapies for traditional disease states: menopause. Am Fam Physician 2002; 66:129-134.
8.Moilanen J, Aalto AM, Hemminki E, Aro AR, Raitanen J, Luoto R. Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas 2010; 67:368-374.
9.Skrzypulec V, Dabrowska J, Drosdzol A. The influence of physical activity level on climacteric symptoms in menopausal women. Climacteric 2010; 13:355-361.
10.Canario AC, Cabral PU, Spyrides MH, Giraldo PC, Eleuterio J, Jr., Goncalves AK. The impact of physical activity on menopausal symptoms in middle-aged women. Int J Gynaecol Obstet 2012; 118:34-36.
11.Whitcomb BW, Whiteman MK, Langenberg P, Flaws JA, Romani WA. Physical activity and risk of hot flashes among women in midlife. J Womens Health (Larchmt) 2007; 16:124-133.
12.Aiello EJ, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Bowen D, et al. Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause 2004; 11:382-388.
13.Daley A, Stokes-Lampard H, Macarthur C. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2011:CD006108.
14.Mirzaiinjmabadi K, Anderson D, Barnes M. The relationship between exercise, Body Mass Index and menopausal symptoms in midlife Australian women. Int J Nurs Pract 2006; 12:28-34.
15.Tan MN, Kartal M, Guldal D. The effect of physical activity and body mass index on menopausal symptoms in Turkish women: a cross-sectional study in primary care. BMC Womens Health 2014; 14:38.
16.Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol 2006; 33:275-284.
17.Thurston RC, Sowers MR, Chang Y, Sternfeld B, Gold EB, Johnston JM, et al. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation. Am J Epidemiol 2008; 167:78-85.
18.Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001; 4:267-272.
19.Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes 2004; 2:45.
20.Gürkan ÖC. The validity and reliability of Turkish version of Menopause Rating Scale [in Turkish]. Hemşirelik Forumu Dergisi 2005; 3:6.
21.Dennerstein L. Well-being, symptoms and the menopausal transition. Maturitas 1996; 23:147-157.
22.Lee MS, Kim JH, Park MS, Yang J, Ko YH, Ko SD, et al. Factors influencing the severity of menopause symptoms in Korean post-menopausal women. J Korean Med Sci 2010; 25:758-765.
23.Uncu Y, Alper Z, Ozdemir H, Bilgel N, Uncu G. The perception of menopause and hormone therapy among women in Turkey. Climacteric 2007; 10:63-71.
24.Daley A, Macarthur C, Stokes-Lampard H, McManus R, Wilson S, Mutrie N. Exercise participation, body mass index, and health-related quality of life in women of menopausal age. Br J Gen Pract 2007; 57:130-135.
25.Daniel M, Martin AD, Carter J. Opiate receptor blockade by naltrexone and mood state after acute physical activity. Br J Sports Med 1992; 26:111-115.
26.Greendale GA, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 2005; 118 Suppl 12B:148-154.
27.Da Fonseca AM, Bagnoli VR, Souza MA, Azevedo RS, Couto Ede B, Jr., Soares JM, Jr., et al. Impact of age and body mass on the intensity of menopausal symptoms in 5968 Brazilian women. Gynecol Endocrinol 2013; 29:116-118.
28.Al-Safi ZA, Polotsky AJ. Obesity and menopause. Best Pract Res Clin Obstet Gynaecol 2015; 29:548-553.
29.Freeman EW, Sammel MD, Grisso JA, Battistini M, Garcia-Espagna B, Hollander L. Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women. J Womens Health Gend Based Med 2001; 10:67-76.
Year 2020,
Volume: 17 Issue: 1, 269 - 274, 31.03.2020
Vehbi Yavuz Tokgöz
,
Şebnem Alanya Tosun
References
- 1.Mishra G, Kuh D. Perceived change in quality of life during the menopause. Soc Sci Med 2006; 62:93-102.
2.Dennerstein L, Smith AM, Morse C. Psychological well-being, mid-life and the menopause. Maturitas 1994; 20:1-11.
3.Greendale GA, Lee NP, Arriola ER. The menopause. Lancet 1999; 353:571-580.
4.North American Menopause S. Treatment of menopause-associated vasomotor symptoms: position statement of The North American Menopause Society. Menopause 2004; 11:11-33.
5.Woods NF, Mitchell ES. Symptoms during the perimenopause: prevalence, severity, trajectory, and significance in women's lives. Am J Med 2005; 118 Suppl 12B:14-24.
6.de Villiers TJ, Gass ML, Haines CJ, Hall JE, Lobo RA, Pierroz DD, et al. Global consensus statement on menopausal hormone therapy. Climacteric 2013; 16:203-204.
7.Morelli V, Naquin C. Alternative therapies for traditional disease states: menopause. Am Fam Physician 2002; 66:129-134.
8.Moilanen J, Aalto AM, Hemminki E, Aro AR, Raitanen J, Luoto R. Prevalence of menopause symptoms and their association with lifestyle among Finnish middle-aged women. Maturitas 2010; 67:368-374.
9.Skrzypulec V, Dabrowska J, Drosdzol A. The influence of physical activity level on climacteric symptoms in menopausal women. Climacteric 2010; 13:355-361.
10.Canario AC, Cabral PU, Spyrides MH, Giraldo PC, Eleuterio J, Jr., Goncalves AK. The impact of physical activity on menopausal symptoms in middle-aged women. Int J Gynaecol Obstet 2012; 118:34-36.
11.Whitcomb BW, Whiteman MK, Langenberg P, Flaws JA, Romani WA. Physical activity and risk of hot flashes among women in midlife. J Womens Health (Larchmt) 2007; 16:124-133.
12.Aiello EJ, Yasui Y, Tworoger SS, Ulrich CM, Irwin ML, Bowen D, et al. Effect of a yearlong, moderate-intensity exercise intervention on the occurrence and severity of menopause symptoms in postmenopausal women. Menopause 2004; 11:382-388.
13.Daley A, Stokes-Lampard H, Macarthur C. Exercise for vasomotor menopausal symptoms. Cochrane Database Syst Rev 2011:CD006108.
14.Mirzaiinjmabadi K, Anderson D, Barnes M. The relationship between exercise, Body Mass Index and menopausal symptoms in midlife Australian women. Int J Nurs Pract 2006; 12:28-34.
15.Tan MN, Kartal M, Guldal D. The effect of physical activity and body mass index on menopausal symptoms in Turkish women: a cross-sectional study in primary care. BMC Womens Health 2014; 14:38.
16.Matsushita T, Hasegawa M, Hamaguchi Y, Takehara K, Sato S. Longitudinal analysis of serum cytokine concentrations in systemic sclerosis: association of interleukin 12 elevation with spontaneous regression of skin sclerosis. J Rheumatol 2006; 33:275-284.
17.Thurston RC, Sowers MR, Chang Y, Sternfeld B, Gold EB, Johnston JM, et al. Adiposity and reporting of vasomotor symptoms among midlife women: the study of women's health across the nation. Am J Epidemiol 2008; 167:78-85.
18.Soules MR, Sherman S, Parrott E, Rebar R, Santoro N, Utian W, et al. Executive summary: Stages of Reproductive Aging Workshop (STRAW). Climacteric 2001; 4:267-272.
19.Heinemann K, Ruebig A, Potthoff P, Schneider HP, Strelow F, Heinemann LA, et al. The Menopause Rating Scale (MRS) scale: a methodological review. Health Qual Life Outcomes 2004; 2:45.
20.Gürkan ÖC. The validity and reliability of Turkish version of Menopause Rating Scale [in Turkish]. Hemşirelik Forumu Dergisi 2005; 3:6.
21.Dennerstein L. Well-being, symptoms and the menopausal transition. Maturitas 1996; 23:147-157.
22.Lee MS, Kim JH, Park MS, Yang J, Ko YH, Ko SD, et al. Factors influencing the severity of menopause symptoms in Korean post-menopausal women. J Korean Med Sci 2010; 25:758-765.
23.Uncu Y, Alper Z, Ozdemir H, Bilgel N, Uncu G. The perception of menopause and hormone therapy among women in Turkey. Climacteric 2007; 10:63-71.
24.Daley A, Macarthur C, Stokes-Lampard H, McManus R, Wilson S, Mutrie N. Exercise participation, body mass index, and health-related quality of life in women of menopausal age. Br J Gen Pract 2007; 57:130-135.
25.Daniel M, Martin AD, Carter J. Opiate receptor blockade by naltrexone and mood state after acute physical activity. Br J Sports Med 1992; 26:111-115.
26.Greendale GA, Gold EB. Lifestyle factors: are they related to vasomotor symptoms and do they modify the effectiveness or side effects of hormone therapy? Am J Med 2005; 118 Suppl 12B:148-154.
27.Da Fonseca AM, Bagnoli VR, Souza MA, Azevedo RS, Couto Ede B, Jr., Soares JM, Jr., et al. Impact of age and body mass on the intensity of menopausal symptoms in 5968 Brazilian women. Gynecol Endocrinol 2013; 29:116-118.
28.Al-Safi ZA, Polotsky AJ. Obesity and menopause. Best Pract Res Clin Obstet Gynaecol 2015; 29:548-553.
29.Freeman EW, Sammel MD, Grisso JA, Battistini M, Garcia-Espagna B, Hollander L. Hot flashes in the late reproductive years: risk factors for Africa American and Caucasian women. J Womens Health Gend Based Med 2001; 10:67-76.